StockRing.com   Home    DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH   
  iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   
 4/20/2014, (NASDAQ:PFE), $30.25 +0.16, +0.53%, "HOLD" Pfize Stock
 




  
  

PFE rating is generated by our FREE iPhone App Buy-Sell-Hold+ that covers 4,030 stocks & ETFs

On   4/20/2014   StockRing.com recommends to   "HOLD"   PFE   stock at current price of   $30.25.
Today PFE stock opened at $30.19 and was trading in the daily range of $ 868630 per share.
Pfize (NASDAQ:PFE) Market capitalization is $193.1B. PFE average daily volume is N/A.
On last trading session PFE stock traded 26,536,812 shares. Also the Short Ratio for (NASDAQ:PFE) stock is 51.584B.
Last year Pfize(NASDAQ:PFE) before taxes (EBITDA) (ttm) earned $30.45 on revenue of $2.52.
PFE 50-Day Moving Average is $23.123B vs. $30.25 now and 200-Day Moving Average is $31.65 vs. $30.25.
--------------------------------------------------------------------------------------------------------------------
VIX is "HOLD".  Nasdaq is "BUY".  S&P 500 is "BUY" on  4/17/2014
--------------------------------------------------------------------------------------------------------------------
PFE Earnings Per Share - EPS (ttm) is 3.19. PFE Stock Price Per Earnings ratio - P/E is 9.43.
Pfize(NASDAQ:PFE) stock pays a dividend of $ Inc. Comm" per share which is a yield of "NYSE"%.
On average analysts predict that One Year Target Estimated price for PFE stock is $31.02.
In the last 52 weeks PFE stock was trading in the range of $27.12 - 32.96.
 
 
  Our FREE iPhone App Buy-Sell-Hold ratings for 4459 stocks & ETFs:
 
1. DOW30+    Part 1    199 Stocks    Updated: 4/17/2014 1:36:28 AM
2. DOW30+    Part 2    192 Stocks    Updated: 4/17/2014 1:50:47 AM
3. DOW30+    Part 3    193 Stocks    Updated: 4/17/2014 1:55:09 AM
4. DOW30+    Part 4    195 Stocks    Updated: 4/17/2014 1:59:27 AM
 
5. ENERGY    Part 1    188 Stocks    Updated: 4/18/2014 10:46:27 AM
6. ENERGY    Part 2    186 Stocks    Updated: 4/18/2014 10:51:32 AM
7. ENERGY    Part 3    196 Stocks    Updated: 4/18/2014 10:56:58 AM
 
8. HEALTH    Part 1    184 Stocks    Updated: 4/16/2014 2:02:40 AM
9. HEALTH    Part 2    138 Stocks    Updated: 4/16/2014 2:07:27 AM
 
10. FINANCE    Part 1    191 Stocks    Updated: 11/13/2013 10:58:43 AM
11. FINANCE    Part 2    193 Stocks    Updated: 11/13/2013 12:29:31 PM
12. FINANCE    Part 3    188 Stocks    Updated: 11/13/2013 12:42:47 PM
13. FINANCE    Part 4    188 Stocks    Updated: 11/13/2013 12:46:35 PM
14. FINANCE    Part 5    190 Stocks    Updated: 11/13/2013 10:52:57 AM
 
15. SERVICE    Part 1    181 Stocks    Updated: 11/12/2013 11:38:45 PM
16. SERVICE    Part 2    186 Stocks    Updated: 11/12/2013 11:43:21 PM
17. SERVICE    Part 3    183 Stocks    Updated: 11/12/2013 11:48:07 PM
18. SERVICE    Part 4    193 Stocks    Updated: 11/12/2013 11:53:13 PM
 
19. TECH    Part 1    187 Stocks    Updated: 4/17/2014 11:25:01 PM
20. TECH    Part 2    183 Stocks    Updated: 4/17/2014 11:29:45 PM
21. TECH    Part 3    185 Stocks    Updated: 4/17/2014 11:34:24 PM
22. TECH    Part 4    102 Stocks    Updated: 4/17/2014 11:37:10 PM
 
23. IPOs    200 Stocks    Updated: 4/18/2014 7:17:48 PM
 
24. ETFs    Part 1    200 Stocks    Updated: 11/18/2013 12:58:25 AM
25. ETFs    Part 2    200 Stocks    Updated: 11/18/2013 1:04:02 AM
26. ETFs    Part 3    6 Stocks    Updated: 11/18/2013 1:10:14 AM

BUY  DOW 30+:    ENERGY: CDW  CBA  TSRE  QIWI  EIGI     HEALTH: EWN  EPP  NYC  TOK  IWW 
      FINANCE: XHB  XLI  SHM  XTN  GURU     SERVICES: BRAQ  ASEA  MLPJ  CHIM  PERM     TECH: CSGP  WDC  ONNN  RENN  JNPR 
SELL  DOW 30+: GGB     ENERGY: MKTO  Q  HASI  SRLP  TSC     HEALTH: GNMA 
      FINANCE: ICOL  LEDD  JJG  GREK  VXX     SERVICES: CNPF     TECH: BRKR  CPHD  IPGP  LLTC  MDRX 


Samples of StockRing Real Time "Buy-Sell-Hold" stock Ratings:



  Enter Stock:  
  
    
    
 
 



Download StockRing Free  Buy-Sell-Hold iPhone
App for 1,200 stocks in Energy Healthcare Finance Services & Tech


DOW 30+

ENERGY

HEALTH

FINANCE

SERVICES

TECH

BUY  DOW 30+:    ENERGY: WPT  WBB  VOYA  VMEM  TSRE     HEALTH: VEGI  USMV  URTH  TZY  TZW 
      FINANCE: XVZ  XTN  XSW  XRT  XPH     SERVICES: PERM  MLPJ  CHIM  BRAQ  ASEA     TECH: WDC  SWIR  RENN  ONNN  NTAP 
SELL  DOW 30+: GGB     ENERGY: XON  XGTI  UBIC  TSC  TNDM     HEALTH: GNMA 
      FINANCE: VXX  SGG  SGAR  LEDD  JJG     SERVICES: CNPF     TECH: YNDX  XRX  XLNX  WIT  WCC 

 DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH
  Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   

Our FREE iPhone App with Buy-Sell-Hold ratings for 4,030 stocks:

  iPhone App Buy-Sell-Hold Ratings for 5-5-2013
           
           
           
           
     
  

 
  Enter Stock:  
  
    
    
 



4/20/2014  Sunday, April 20, 2014 (Irvine, California) Today StockRing.com Recommendation is to "HOLD"for Pfize (NASDAQ:PFE) Stock. PFE stock opening price was $30.19 per share. Current price of NASDAQ:PFE Stock is $30.25 per share and it is $+0.16, (+0.53%) today and it was trading in the daily range of $868630 per share. Current Bid Price for (NASDAQ:PFE) stock is $3.26 and the Ask Price is $30.24. In the last 52 weeks PFE stock was trading in the range of $27.12 - 32.96. 50-Day Moving Average for (NASDAQ:PFE) stock is $23.123B and 200-Day Moving Average is $31.65. On average analysts predict that One Year Target Estimated price for (NASDAQ:PFE) stock is $31.02.

Pfize (NASDAQ:PFE) is rated as a wait on 4/17/2014 1:36:28 AM.

Pfize (NASDAQ:PFE) Market capitalization is $193.1B. (NASDAQ:PFE) stock average daily volume is N/A shares per day. However, on last trading session of Apr 17, 2012 PFE stock traded 26,536,812 shares. Also The Number of days it would take short sellers on average to repurchase all the borrowed shares or Short Ratio for (NASDAQ:PFE) stock is 51.584B. On previous trading session PFE Stock closed at $30.09 per share.

Last year Pfize (NASDAQ:PFE) before taxes (EBITDA) (ttm) earned $30.45 on total revenue of $2.52. Earnings Per Share - EPS (ttm) for PFE stock is 3.19. Also, (NASDAQ:PFE) Stock Price Per Earnings ratio - P/E is 9.43. Thus, (NASDAQ:PFE) Stock Price/Sales (ttm) ratio is 34.15 and Price/Book (mrq) ratio is 3.72.

(NASDAQ:PFE) Stock pays a dividend of $ Inc. Comm" per share which is a yield of "NYSE"%. So at this time (NASDAQ:PFE) Stock maintains Trailing Annual Dividend Rate at 2.00.


StockRing Recommendations for Pfize (NASDAQ:PFE) Stock are updated daily here

http://StockRing.com/sr/Buy-Sell-Hold-Stock-Analysis-Ratings.asp?StockName=PFE

At this time StockRing recommends to buy LONG positions on many stocks from Dow 30+ stocks that currently have a BUY or SUPER BUY rating. If you decide to take a SHORT position and actually sell some stocks sjort right now - please check the section of Dow 30+ stocks that have a SELL or SUPER SELL rating.

If you would like to receive Buy-Sell-Hold ratings for stocks from Energy, Healthcare, Finance, Services & Hi-Tech sectors on your iPhone, then please download Buy-Sell-Hold iPhone App here:


Free Limited or $10 Full Version  Buy-Sell-Hold iPhone App
for 1,200 stocks in Energy, Healthcare, Finance, Services and Tech


DOW 30+

ENERGY

HEALTH

FINANCE

SERVICES

TECH


 
  Enter Stock:  
  
    
    
 
 DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH
  Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   

NASDAQ:PFE Stock Charts:   1d   5d   3m   6m   1y   2y   5y   Max    Options   More Info

PFE rating is generated by our FREE iPhone App Buy-Sell-Hold+ that covers 4,030 stocks & ETFs

4/20/2014 1 Year Stock market price chart for Pfize (NASDAQ:PFE) Stock on Sunday, April 20, 2014
  
1 Year PFE 1 Year Dow Jones
1 Year Nasdaq 1 Year S&P 500
4/20/2014 5 days Stock market price chart for Pfize (NASDAQ:PFE) Stock on Sunday, April 20, 2014
  
5 Days PFE 5 Days Dow Jones
5 Days Nasdaq 5 Days S&P 500
  

EUROs for $1 DOLLAR: 30 days
     

NASDAQ:PFE Stock Charts:   1d   5d   3m   6m   1y   2y   5y   Max    Options   More Info
 DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH
  Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   

PFE rating is generated by our FREE iPhone App Buy-Sell-Hold+ that covers 4,030 stocks & ETFs

4/20/2014 Stock market price quote data for Pfize (NASDAQ:PFE) Stock on Sunday, April 20, 2014

Last Trade: 30.25
Trade Time: Apr 17
Change: +0.16, (+0.53%)
Prev Close: 30.09
Open: 30.19
Bid: 3.26
Ask: 0.98
1y Target Est: $31.02
50-Day Moving Average: 23.123B
200-Day Moving Average:
31.65
Short Ratio: 51.584B
Trailing Annual Dividend Rate: 2.00
Day's Range: 868630
52wk Range: 27.12 - 32.96
Volume: 26,536,812
Avg Vol: N/A
Market Cap: 193.1B
P/E (ttm): 9.43
EPS (ttm): 3.19
Div & Yield: Inc. Comm" ("NYSE"%)
Revenue (ttm): 2.52
Earnings before Tax (EBITDA) (ttm): 30.45
Price/Sales (ttm): 34.15
Price/Book (mrq): 3.72
 DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH
  Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   

  
  
 DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH
  Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   

PFE rating is generated by our FREE iPhone App Buy-Sell-Hold+ that covers 4,030 stocks & ETFs

PFIZER INC(NYSE: PFE) Company Information

Pfizer Inc.
235 East 42nd Street
New York, NY 10017
United States - Map
Phone: 212-573-2323
Fax: 212-573-7851
Web Site: http://www.pfizer.com

PFIZER INC(NYSE: PFE) DETAILS

PFIZER INC(NYSE: PFE) Index Membership: Dow Jones Composite Dow Industrials S&P 100 S&P 500 S&P 1500 Super Comp
PFIZER INC(NYSE: PFE) Sector: Healthcare
PFIZER INC(NYSE: PFE) Industry: Drug Manufacturers - Major
PFIZER INC(NYSE: PFE) Full Time Employees: 75,400

PFIZER INC(NYSE: PFE) BUSINESS SUMMARY

Pfizer Inc. engages in the discovery, development, manufacture, and marketing of prescription medicines for humans and animals worldwide. Its Pharmaceutical segment offers Lipitor for elevated cholesterol levels in the blood; Norvasc for hypertension; Caduet for cardiovascular events; Chantix/Champix for smoking cessation; Lyrica for neuropathic pain; Geodon/Zeldox, a psychotropic agent; and Aricept for Alzheimer?s disease. It also provides Celebrex for arthritis pain, and inflammation and acute pain; Vfend for esophageal candidiasis and blood stream infections; Zyvox for bacterial infections; and Selzentry/Celsentri for adults infected with only CCR5-tropic HIV-1 detectable. In addition, this segment provides Viagra for erectile dysfunction; Detrol and Toviaz for overactive bladder; Camptosar for metastatic colorectal cancer; Sutent, an oral multi-kinase inhibitor; Xalatan/Xalacom for open-angle glaucoma and ocular hypertension; and Genotropin for growth disorders. The company?s Animal Health segment offers parasiticides, anti-inflammatories, antibiotics, vaccines, antiemetics, and anti-obesity agents. It also provides Revolution/Stronghold for dogs and cats; Rimadyl for pain and inflammation associated with canine osteoarthritis and soft tissue orthopedic surgery; Clavamox/Synulox for skin and soft tissue infections; RespiSureOne/StellamuneOne to prevent pneumonia in swine; Bovi-Shield Gold for reproductive and respiratory protection; Dectomax, an injectable and pour-on formulations; Draxxin, an antibiotic for infections in cattle and swine; and Excede to treat infections in dairy cows, beef cattle, and swine. Pfizer Inc. also involves in contract manufacturing and bulk pharmaceutical chemicals businesses. It serves doctors, nurse practitioners, physician assistants, pharmacists, hospitals, pharmacy benefit managers, managed care organizations, and government agencies. The company was founded in 1849 and is headquartered in New York, New York.

PFIZER INC(NYSE: PFE) KEY EXECUTIVES

Mr. Jeffrey B. Kindler , 53 Chairman, Chief Exec. Officer, Chairman of Exec. Committee and Chairman of Exec. Compliance Committee $ 4.58M $ 0

Mr. Frank A. D'Amelio , 51 Chief Financial Officer, Sr. VP of Bus. Operations and Member of Exec. Compliance Committee $ 2.30M $ 0

Mr. Ian C. Read , 55 Group Pres of Worldwide Biopharmaceutical Bus.es and Member of Exec. Compliance Committee $ 2.30M $ 0

Mr. Martin Mackay , 52 Pres of PharmaTherapeutics R&D $ 2.29M $ 0

Mr. Natale S. Ricciardi , 60 Pres of Manufacturing N/A N/A



4/20/2014 Latest stock market news data for Pfize (NASDAQ:PFE) Stock on Sunday, April 20, 2014

 DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH
  Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   

PFE rating is generated by our FREE iPhone App Buy-Sell-Hold+ that covers 4,030 stocks & ETFs

Company Update: Pfizer Inc (NYSE:PFE) Teva settles patent suit with Pfizer ...
Jutia Group - Apr 17, 2014
Pfizer Inc (NYSE:PFE) [Reuters] - Teva Pharmaceutical Industries Ltd signed a deal that allows the Israeli drugmaker to launch a generic version of Pfizer Inc's blockbuster painkiller Celebrex in December. A U.S. court in March invalidated a patent ...
UPDATE 2-Teva settles patent suit with Pfizer over Celebrex - Reuters
Teva Settles Patent Litigation with Pfizer on Celebrex(R) - Wall Street Journal
Pfizer Inc. (NYSE:PFE): Breakthroughs in Vaccines and Oncology
BasicsMedia - Mar 27, 2014
Tomahawk, WI 03/27/2014 (Basicsmedia) - While Pfizer Inc. (NYSE:PFE) got some bad news when its Celebrex patent was invalidated by a U.S.
Pfizer Inc. (NYSE:PFE): Potential New Oncology Therapy
BasicsMedia - Apr 10, 2014
Pfizer Inc. (NYSE:PFE) announced in early February some positive results from a randomized Phase 2 trial of palbociclib in combination with letrozole (for blocking the synthesis of estrogen) in post-menopausal women with estrogen receptor (ER) positive ...
Why Questcor Is Soaring Today While Pfizer Is Down
Bidness Etc - Apr 7, 2014
Pfizer Inc. (PFE) announced yesterday that its phase 2 randomized study, PALOMA-1, of palbociclib combined with letrozole, achieved its primary endpoint.
How Pfizer Inc. (NYSE:PFE) and Questcor Pharmaceuticals (NASDAQ:QCOR ... - iStreetWire
Buzz Stocks: Yahoo! Inc., Potash Corp./Saskatchewan (USA), Questcor ... - Schaeffers Research (blog)
Pfizer Vs. Eli Lilly, Novartis In Breast Cancer Race
Seeking Alpha - Apr 14, 2014
If the company must complete a Phase 3 study, which is already underway, approval might be delayed a couple of years, according to the ISI Group.
Vigo County Parks aquire 824 acres from Pfizer Inc.
MyWabashValley - Mar 27, 2014
The Board closed on 824 acres formerly owned by Pfizer Inc on Tuesday. The land is in southern Vigo County, mostly north of Dallas Road.
Pfizer, AstraZeneca, and Novartis Reveal New Business Developments
Bidness Etc - Mar 21, 2014
With small cap biotech companies flooding the news, Pfizer Inc. (PFE), AstraZeneca plc (ADR) (AZN), and Novartis AG (ADR) (NVS) revealed developments in their businesses.
Healthcare Most Active Stocks: Pfizer Inc. (NYSE:PFE), Gilead Sciences ...
Tech News - Apr 16, 2014
A proxy advisory firm has asked shareholders of the Indian unit of Wyeth to oppose its merger deal with Pfizer Inc. (NYSE:PFE) as the share swap ratio is skewed in favour of Pfizer Inc. (NYSE:PFE). Shareholder Empowerment Services (SES) has made this ...
Pfizer Inc. (NYSE:PFE)'s: Breast Cancer Drug Slowing Tumor Progression
US Trade Media - Apr 15, 2014
Dallas, Texas, 04/15/2014 (ustrademedia) - Recent test studies have shown that experimental breast cancer drugs from Pfizer Inc. (NYSE:PFE) have the capacity to slow or halt the progression of advanced tumors. This should be a great addition as a form ...
Pfizer Price Target Lowered to $36.00 at Jefferies Group (PFE) - WKRB News
Jefferies Group Lowers Pfizer Price Target to $36.00 (PFE) - Zolmax
Why Pfizer (PFE) Stock Is Down On Monday
TheStreet.com - Apr 7, 2014
"We rate PFIZER INC (PFE) a BUY. This is based on the convergence of positive investment measures, which should help this stock outperform the majority of stocks that we rate.
Pfizer shares drop despite positive test for breast-cancer drug - MarketWatch (blog)

 
DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH
  Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   

 DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH
  Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   

PFE rating is generated by our FREE iPhone App Buy-Sell-Hold+ that covers 4,030 stocks & ETFs


4/20/2014 News from StockRing Blog about Pfize (NASDAQ:PFE) Stock on Sunday, April 20, 2014



Copyright © 2012 StockRing.com. All rights reserved.
Subscriber Agreement   Privacy Agreement   Stocks   MutualFunds

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither StockRing.com nor its partners shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the StockRing site, a user agrees not to redistribute the information found therein.